Leber's Hereditary Optic Neuropathy Drug Market, Global Outlook and Forecast 2022-2028

Leber's Hereditary Optic Neuropathy Drug Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281647 | No. of Pages: 74 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Leber's Hereditary Optic Neuropathy Drug in global, including the following market information:
Global Leber's Hereditary Optic Neuropathy Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Leber's Hereditary Optic Neuropathy Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Leber's Hereditary Optic Neuropathy Drug companies in 2021 (%)
The global Leber's Hereditary Optic Neuropathy Drug market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Elamipretide Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leber's Hereditary Optic Neuropathy Drug include Alkeus Pharmaceuticals, Inc., Biovista Inc., GenSight Biologics S.A., Ixchel Pharma, LLC, Khondrion BV, Spark Therapeutics, Inc. and Stealth BioTherapeutics Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leber's Hereditary Optic Neuropathy Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leber's Hereditary Optic Neuropathy Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber's Hereditary Optic Neuropathy Drug Market Segment Percentages, by Type, 2021 (%)
    Elamipretide
    GS-011
    IXC-201
    KH-176
    Others
Global Leber's Hereditary Optic Neuropathy Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber's Hereditary Optic Neuropathy Drug Market Segment Percentages, by Application, 2021 (%)
    Hospital
    Clinic
    Others
Global Leber's Hereditary Optic Neuropathy Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber's Hereditary Optic Neuropathy Drug Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leber's Hereditary Optic Neuropathy Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Leber's Hereditary Optic Neuropathy Drug revenues share in global market, 2021 (%)
Key companies Leber's Hereditary Optic Neuropathy Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Leber's Hereditary Optic Neuropathy Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Alkeus Pharmaceuticals, Inc.
    Biovista Inc.
    GenSight Biologics S.A.
    Ixchel Pharma, LLC
    Khondrion BV
    Spark Therapeutics, Inc.
    Stealth BioTherapeutics Inc.
1 Introduction to Research & Analysis Reports
    1.1 Leber's Hereditary Optic Neuropathy Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Leber's Hereditary Optic Neuropathy Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Leber's Hereditary Optic Neuropathy Drug Overall Market Size
    2.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size: 2021 VS 2028
    2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Leber's Hereditary Optic Neuropathy Drug Sales: 2017-2028
3 Company Landscape
    3.1 Top Leber's Hereditary Optic Neuropathy Drug Players in Global Market
    3.2 Top Global Leber's Hereditary Optic Neuropathy Drug Companies Ranked by Revenue
    3.3 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Companies
    3.4 Global Leber's Hereditary Optic Neuropathy Drug Sales by Companies
    3.5 Global Leber's Hereditary Optic Neuropathy Drug Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Leber's Hereditary Optic Neuropathy Drug Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Leber's Hereditary Optic Neuropathy Drug Players in Global Market
        3.8.1 List of Global Tier 1 Leber's Hereditary Optic Neuropathy Drug Companies
        3.8.2 List of Global Tier 2 and Tier 3 Leber's Hereditary Optic Neuropathy Drug Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Leber's Hereditary Optic Neuropathy Drug Market Size Markets, 2021 & 2028
        4.1.2 Elamipretide
        4.1.3 GS-011
        4.1.4 IXC-201
        4.1.5 KH-176
        4.1.6 Others
    4.2 By Type - Global Leber's Hereditary Optic Neuropathy Drug Revenue & Forecasts
        4.2.1 By Type - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2022
        4.2.2 By Type - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2023-2028
        4.2.3 By Type - Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share, 2017-2028
    4.3 By Type - Global Leber's Hereditary Optic Neuropathy Drug Sales & Forecasts
        4.3.1 By Type - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2022
        4.3.2 By Type - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2023-2028
        4.3.3 By Type - Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share, 2017-2028
    4.4 By Type - Global Leber's Hereditary Optic Neuropathy Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Leber's Hereditary Optic Neuropathy Drug Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Leber's Hereditary Optic Neuropathy Drug Revenue & Forecasts
        5.2.1 By Application - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2022
        5.2.2 By Application - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2023-2028
        5.2.3 By Application - Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share, 2017-2028
    5.3 By Application - Global Leber's Hereditary Optic Neuropathy Drug Sales & Forecasts
        5.3.1 By Application - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2022
        5.3.2 By Application - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2023-2028
        5.3.3 By Application - Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share, 2017-2028
    5.4 By Application - Global Leber's Hereditary Optic Neuropathy Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Leber's Hereditary Optic Neuropathy Drug Market Size, 2021 & 2028
    6.2 By Region - Global Leber's Hereditary Optic Neuropathy Drug Revenue & Forecasts
        6.2.1 By Region - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2022
        6.2.2 By Region - Global Leber's Hereditary Optic Neuropathy Drug Revenue, 2023-2028
        6.2.3 By Region - Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share, 2017-2028
    6.3 By Region - Global Leber's Hereditary Optic Neuropathy Drug Sales & Forecasts
        6.3.1 By Region - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2022
        6.3.2 By Region - Global Leber's Hereditary Optic Neuropathy Drug Sales, 2023-2028
        6.3.3 By Region - Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2028
        6.4.2 By Country - North America Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2028
        6.4.3 US Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.4.4 Canada Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.4.5 Mexico Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2028
        6.5.2 By Country - Europe Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2028
        6.5.3 Germany Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.4 France Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.5 U.K. Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.6 Italy Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.7 Russia Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.8 Nordic Countries Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.5.9 Benelux Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2028
        6.6.2 By Region - Asia Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2028
        6.6.3 China Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.6.4 Japan Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.6.5 South Korea Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.6.6 Southeast Asia Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.6.7 India Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2028
        6.7.2 By Country - South America Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2028
        6.7.3 Brazil Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.7.4 Argentina Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales, 2017-2028
        6.8.3 Turkey Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.8.4 Israel Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.8.5 Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
        6.8.6 UAE Leber's Hereditary Optic Neuropathy Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Alkeus Pharmaceuticals, Inc.
        7.1.1 Alkeus Pharmaceuticals, Inc. Corporate Summary
        7.1.2 Alkeus Pharmaceuticals, Inc. Business Overview
        7.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.1.4 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.1.5 Alkeus Pharmaceuticals, Inc. Key News
    7.2 Biovista Inc.
        7.2.1 Biovista Inc. Corporate Summary
        7.2.2 Biovista Inc. Business Overview
        7.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.2.4 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.2.5 Biovista Inc. Key News
    7.3 GenSight Biologics S.A.
        7.3.1 GenSight Biologics S.A. Corporate Summary
        7.3.2 GenSight Biologics S.A. Business Overview
        7.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.3.4 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.3.5 GenSight Biologics S.A. Key News
    7.4 Ixchel Pharma, LLC
        7.4.1 Ixchel Pharma, LLC Corporate Summary
        7.4.2 Ixchel Pharma, LLC Business Overview
        7.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.4.4 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.4.5 Ixchel Pharma, LLC Key News
    7.5 Khondrion BV
        7.5.1 Khondrion BV Corporate Summary
        7.5.2 Khondrion BV Business Overview
        7.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.5.4 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.5.5 Khondrion BV Key News
    7.6 Spark Therapeutics, Inc.
        7.6.1 Spark Therapeutics, Inc. Corporate Summary
        7.6.2 Spark Therapeutics, Inc. Business Overview
        7.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.6.4 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.6.5 Spark Therapeutics, Inc. Key News
    7.7 Stealth BioTherapeutics Inc.
        7.7.1 Stealth BioTherapeutics Inc. Corporate Summary
        7.7.2 Stealth BioTherapeutics Inc. Business Overview
        7.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Major Product Offerings
        7.7.4 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales and Revenue in Global (2017-2022)
        7.7.5 Stealth BioTherapeutics Inc. Key News
8 Global Leber's Hereditary Optic Neuropathy Drug Production Capacity, Analysis
    8.1 Global Leber's Hereditary Optic Neuropathy Drug Production Capacity, 2017-2028
    8.2 Leber's Hereditary Optic Neuropathy Drug Production Capacity of Key Manufacturers in Global Market
    8.3 Global Leber's Hereditary Optic Neuropathy Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Leber's Hereditary Optic Neuropathy Drug Supply Chain Analysis
    10.1 Leber's Hereditary Optic Neuropathy Drug Industry Value Chain
    10.2 Leber's Hereditary Optic Neuropathy Drug Upstream Market
    10.3 Leber's Hereditary Optic Neuropathy Drug Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Leber's Hereditary Optic Neuropathy Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com